Target (TGT) gains as CVS buys drug arm

Loading...
Loading...
Target Corp.
TGT
shares gained 1.6% to $80.71 after agreeing to have its pharmacy and clinic business purchased by CVS Health Corp. for $1.9 billion. Share volume was 564,000, compared to an all-day average of 1.1 million
Market News and Data brought to you by Benzinga APIs
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...